CIK 0001811063
- Non-accelerated filer
- Smaller reporting company
Nuvation Bio Inc.
Sign in to watch- Ticker
- NUVB
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 850862255
- Phone
- +1 332-208-6102
- Business address
- 1 PENNSYLVANIA PLAZA, SUITE 3805, NEW YORK, NY, 10019
- Former names
- Panacea Acquisition Corp
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Conversion CEO, ANHEART THERAPEUTICS LTD. acquired 4,239,300 shares (conversion)
- 4 Conversion Director acquired 19,004,200 shares (conversion)
- 4 Open-market buy Director bought 277,895 shares at $2.97 ($825,348)
- 4 Open-market buy Director bought 500,000 shares at an average $2.98 ($1,492,385)
- 4 Open-market buy Director bought 172,189 shares at $2.90 ($500,089)
- 4 Exercise or conversion Director acquired 659,947 shares (option exercise)
- 4 Grant or award Director acquired 6,172,344 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Grant or award CEO, ANHEART THERAPEUTICS LTD. acquired 1,929,747 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 4 of 10 · 184 filings